Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol
This report describes the occurrence of asymptomatic hyperkalemia induced by the sequential administration of metoprolol and carvedilol in an 81-year-old man with type II diabetes and stable stage III renal insufficiency. The potassium level rose to 5.6–5.7 mEq/L with metoprolol and normalized when...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Cardiology |
Online Access: | http://dx.doi.org/10.1155/2018/7686373 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832554703229026304 |
---|---|
author | S. Serge Barold Scott Upton |
author_facet | S. Serge Barold Scott Upton |
author_sort | S. Serge Barold |
collection | DOAJ |
description | This report describes the occurrence of asymptomatic hyperkalemia induced by the sequential administration of metoprolol and carvedilol in an 81-year-old man with type II diabetes and stable stage III renal insufficiency. The potassium level rose to 5.6–5.7 mEq/L with metoprolol and normalized when the agent was discontinued. However, the potassium level rose again to 5.6 mEq/L after the administration of carvedilol but the level normalized by halving the dose. The observations of hyperkalemia induced by two different β-blocker drugs in the same patient confirm that this side effect is common to all β-blocker drugs. |
format | Article |
id | doaj-art-531d9db47817423eb4218c740e5cbe3f |
institution | Kabale University |
issn | 2090-6404 2090-6412 |
language | English |
publishDate | 2018-01-01 |
publisher | Wiley |
record_format | Article |
series | Case Reports in Cardiology |
spelling | doaj-art-531d9db47817423eb4218c740e5cbe3f2025-02-03T05:50:48ZengWileyCase Reports in Cardiology2090-64042090-64122018-01-01201810.1155/2018/76863737686373Hyperkalemia Induced by the Sequential Administration of Metoprolol and CarvedilolS. Serge Barold0Scott Upton1Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USASan Diego Internal Medicine and Pediatrics Associates, San Diego, CA, USAThis report describes the occurrence of asymptomatic hyperkalemia induced by the sequential administration of metoprolol and carvedilol in an 81-year-old man with type II diabetes and stable stage III renal insufficiency. The potassium level rose to 5.6–5.7 mEq/L with metoprolol and normalized when the agent was discontinued. However, the potassium level rose again to 5.6 mEq/L after the administration of carvedilol but the level normalized by halving the dose. The observations of hyperkalemia induced by two different β-blocker drugs in the same patient confirm that this side effect is common to all β-blocker drugs.http://dx.doi.org/10.1155/2018/7686373 |
spellingShingle | S. Serge Barold Scott Upton Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol Case Reports in Cardiology |
title | Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol |
title_full | Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol |
title_fullStr | Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol |
title_full_unstemmed | Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol |
title_short | Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol |
title_sort | hyperkalemia induced by the sequential administration of metoprolol and carvedilol |
url | http://dx.doi.org/10.1155/2018/7686373 |
work_keys_str_mv | AT ssergebarold hyperkalemiainducedbythesequentialadministrationofmetoprololandcarvedilol AT scottupton hyperkalemiainducedbythesequentialadministrationofmetoprololandcarvedilol |